What is Phosphorus?
Phosphorus operates as a sophisticated, verticalized genetic testing platform that bridges the gap between complex wet lab chemistry and advanced bioinformatics software. By controlling the entire stack, the company delivers medical-grade genetic insights at accessible price points, effectively democratizing genomic information for a broader patient demographic. Beyond direct-to-consumer and clinical applications, Phosphorus distinguishes itself through a robust genomics-as-a-service model. This white-labeling capability allows healthcare organizations to deploy their own preventative genetic testing solutions, thereby facilitating the integration of genomics into routine clinical practice. The company's infrastructure is designed to empower providers with actionable data, shifting the medical paradigm from reactive treatment to proactive, preventative care.
How much funding has Phosphorus raised?
Phosphorus has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2016): $10M with participation from FirstMark Capital
Key Investors in Phosphorus
FirstMark Capital
FirstMark is an early-stage venture capital firm headquartered in New York City that backs exceptional founders and provides a platform designed to accelerate growth through transformative access to networks, customers, and top talent.
What's next for Phosphorus?
With the infusion of capital, Phosphorus is expected to deepen its market penetration by expanding its white-label partnerships and enhancing its bioinformatics capabilities. The company is currently in a phase of rapid scaling, moving beyond initial development to establish a dominant footprint in the enterprise healthcare sector. Future strategic initiatives will likely focus on increasing the throughput of its laboratory operations and refining its software suite to support larger clinical datasets. As the demand for preventative genomics continues to rise, Phosphorus is well-positioned to capitalize on the shift toward personalized medicine, leveraging its comprehensive platform to set new benchmarks for accuracy and accessibility in the diagnostic industry.
See full Phosphorus company page
